Eikon Therapeutics Ownership | Who Owns Eikon Therapeutics?
Eikon Therapeutics Ownership Summary
Eikon Therapeutics is owned by 49.29% institutional investors, 17.38% insiders, and 33.34% retail investors. Fmr is the largest institutional shareholder, holding 10.19% of EIKN shares. BGF World Healthscience A2 is the top mutual fund, with 2.81% of its assets in Eikon Therapeutics shares.
EIKN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Eikon Therapeutics | 49.29% | 17.38% | 33.34% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 5.52M | 10.19% | $44.38M |
| Blackrock funding, inc. /de | 4.87M | 8.99% | $39.15M |
| Merck | 1.67M | 3.08% | $13.40M |
| Capital world investors | 1.18M | 2.17% | $9.45M |
| Vanguard capital management | 1.02M | 1.88% | $8.16M |
| Geode capital management | 754.50K | 1.39% | $6.07M |
| Regents of the university of california | 635.13K | 1.17% | $5.11M |
| State street | 608.84K | 1.12% | $4.90M |
| Soros capital management | 484.67K | 0.90% | $3.90M |
| Walleye capital | 391.27K | 0.72% | $3.15M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Soros capital management | 484.67K | 2.14% | $3.90M |
| Merck | 1.67M | 1.63% | $13.40M |
| Entrypoint capital | 47.94K | 0.11% | $385.46K |
| Affinity asset advisors | 298.00K | 0.10% | $2.40M |
| Regents of the university of california | 635.13K | 0.08% | $5.11M |
| Dcf advisers | 33.79K | 0.06% | $271.69K |
| Pavaki capital management | 10.00K | 0.03% | $80.40K |
| Entropy technologies, lp | 15.50K | 0.00% | $124.62K |
| Walleye capital | 391.27K | 0.00% | $3.15M |
| Alps advisors | 71.25K | 0.00% | $572.89K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Regents of the university of california | 635.13K | 0.08% | 635.13K |
| Blackrock funding, inc. /de | 4.87M | 0.00% | 587.85K |
| Fmr | 5.52M | 0.00% | 526.25K |
| Walleye capital | 391.27K | 0.00% | 391.27K |
| State street | 608.84K | 0.00% | 254.75K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jane street group | - | - | -265.00K |
| Wellington management group llp | - | - | -185.00K |
| Sixth street partners management company | - | - | -182.10K |
| Blackstone | - | - | -168.34K |
| Goldman sachs group | - | - | -129.31K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Regents of the university of california | 635.13K | 0.08% | 635.13K | $5.11M |
| Walleye capital | 391.27K | 0.00% | 391.27K | $3.15M |
| Los angeles capital management | 63.83K | 0.00% | 63.83K | $513.19K |
| Entrypoint capital | 47.94K | 0.11% | 47.94K | $385.46K |
| Dcf advisers | 33.79K | 0.06% | 33.79K | $271.69K |
Sold Out
| Holder | Change |
|---|---|
| Quantbot technologies lp | -1.10K |
| Strs ohio | -4.30K |
| Landscape capital management | -10.38K |
| Hudson bay capital management lp | -13.48K |
| Axq capital, lp | -15.41K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 78 | 50.00% | 26,687,462 | 12.40% | 49 | 2.56% | 55 | 5.77% | 9 | - |
| Mar 31, 2026 | 52 | - | 23,743,113 | - | 43 | - | 52 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BGF World Healthscience A2 | 1.52M | 2.81% | - |
| Fidelity Contrafund | 1.27M | 2.35% | -2.08K |
| Fidelity Select Biotechnology | 1.17M | 2.16% | 18.20K |
| American Funds SMALLCAP World A | 1.14M | 2.11% | - |
| T. Rowe Price Small-Cap Value | 848.85K | 1.57% | - |
| Fidelity Growth Compy Commingled Pl S | 839.77K | 1.55% | 34.50K |
| iShares Russell 2000 ETF | 788.07K | 1.45% | - |
| T. Rowe Price New Horizons | 739.38K | 1.36% | -91.63K |
| Fidelity Growth Company Fund | 730.92K | 1.35% | 97.60K |
| BlackRock Health Sciences Opps Inv A | 722.39K | 1.33% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 03, 2026 | Column Group IV GP, LP | - | Buy | $1.03M |
EIKN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools